Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Litorina V and the Bergfalk group
Mandate

Vinge has advised Litorina V and the Bergfalk group

June 15, 2018 Banking and Finance

Vinge has advised Litorina V and the Bergfalk group in connection with the acquisition of Johan i Hallen i Göteborg AB, a leading Swedish distributor within fresh food with focus on meat.

The company has a turnover of over SEK 640 million and offers its products in Sweden. The company's former main owners and management will remain as significant owners going forward. Through the transaction a partnership is established between the Bergfalk-group and Johan i Hallen creating one of the leading specialist distributors within fresh food with focus on meat, fish and shellfish.

Vinge’s team consisted of partner Jonas Johansson together with the associates Carl Sander and Martin Cronsioe (M&A), Sara Strandberg and Sophia Holm (employment), Kristoffer Larson (real estate), Arvid Axelryd (IP) and Johan Cederblad (environment. Johan Wahlbom provided competition law advice. Partner Louise Brorsson Salomon and associate Sebastian Frisk assisted with the financing.
 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025